MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Botulinum Toxin Outcomes in Patients with Lower Limb Dystonia

    M. Wajid, J. Frey, L. Kugler, T. Stiep, J. Yu, J. Toledo, J. Lopes, A. Ramirez-Zamora, A. Rawls, A. Wagle Shukla, I. Malaty (Gainesville, USA)

    Objective: To assess botulinum toxin outcomes in patients with lower limb dystonia. Background: One of the most effective treatments for dystonia is botulinum toxin (BoNT)…
  • 2022 International Congress

    Retinal thickness as a marker of disease progression in progressive supranuclear palsy

    Y. Chen, H. Wang, B. Wang, B. Li, P. Ye, W. Xu, P. Liu, X. Chen, Z. Cen, Z. Ouyang, S. Wu, X. Dou, Y. Liao, W. Luo (Hangzhou, China)

    Objective: We measured changes of retinal thickness, and compare them with clinical features and intracranial neurodegeneration in progressive supranuclear palsy (PSP) cohort. Background: PSP has a…
  • 2022 International Congress

    A Literature Review: Effectiveness of Transcranial Direct Current Stimulation on gait speed and freezing of gait in patients with Parkinson’s disease

    T. Mok (hong kong, Hong Kong)

    Objective: The objective of this review is to update evidence on benefits of tDCS on gait speed and freezing of gait (FOG) for PD patients…
  • 2022 International Congress

    Cerebellar sodium disequilibrium in a patient with ATP1A3-related rapid onset dystonia-parkinsonism

    J. Prasuhn, M. Göttlich, S. Großer, K. Reuther, B. Ebeling, A. Münchau, A. Nagel, N. Brüggemann (Lübeck, Germany)

    Objective: Here, we applied non-invasive 23Na Magnetic Resonance Imaging to study pathophysiology-related changes in the total and intracellular sodium content in a patient with rapid-onset…
  • 2022 International Congress

    Prevention and management of Deep Brain Stimulation (DBS) surgical site infections (SSI) – multicentre survey of UK practice.

    S. Perides, J. Candelario-Mckeown, M. Kaminska, H. Hasegawa (London, United Kingdom)

    Objective: The aim of this survey was to better understand trends, patterns and practices of DBS surgical site care in the UK. Background: Deep brain…
  • 2022 International Congress

    Alien hand syndrome in ischemic stroke: a case-report

    K. Manysheva (Makhachkala, Russian Federation)

    Objective: Alien hand syndrome (AHS) is a rare movement disorder that inspires fear to patients and confuses doctors. So we describe a rare case-report. Background:…
  • 2022 International Congress

    The Journey Of Levodopa Treatment in Parkinson’s disease

    B. Pandey (Tirupati, India)

    Objective: This study aims to relook the journey of levodopa in the treatment of Parkinson’s disease. Background: Levodopa has been used in the treatment of…
  • 2022 International Congress

    Bitopertin, a GlyT1 inhibitor, attenuates the development of dyskinesia in the 6-OHDA-lesioned rat

    I. Frouni, W. Kang, D. Bédard, S. Belliveau, C. Kwan, A. Hamadjida, P. Huot (Montreal, Canada)

    Objective: To evaluate the effect of the glycine transporter 1 (GlyT1) inhibitor bitopertin at preventing dyskinesia development in the 6-hydroxydopamine (6-OHDA)-lesioned rat model of Parkinson’s…
  • 2022 International Congress

    Real-World Treatment Patterns and Outcomes in Patients With Chorea Associated With Huntington Disease Using Tetrabenazine or Deutetrabenazine in Combination with Antipsychotic Drugs

    D. Claassen, H. Romdhani, R. Ayyagari, D. Goldschmidt, S. Zoye Moroz, A. Hernandez, S. Leo (Nashville, USA)

    Objective: To describe treatment patterns with vesicular monoamine transporter 2 inhibitors (VMAT2i; tetrabenazine [TBZ], or deutetrabenazine [DTBZ]) in combination with antipsychotic agents (APs) in patients…
  • 2022 International Congress

    Detection of specific antigens in immune-mediated cerebellar ataxias

    A. Kudo, H. Yaguchi, M. Abe, A. Nagai, S. Shirai, I. Takahashi-Iwata, M. Matsushima, M. Watanabe, S. Hatakeyama, I. Yabe (Sapporo, Japan)

    Objective: We aimed to clarify biomarkers and pathogenic autoantibodies in cerebellar ataxia, especially multiple system atrophy (MSA) and immune-mediated cerebellar ataxias (IMCAs), by detection of…
  • « Previous Page
  • 1
  • …
  • 75
  • 76
  • 77
  • 78
  • 79
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley